Clinical Outcomes of Root Canal Treatment Using Modern Irrigation Protocols

September 25, 2026 updated by: University of Illinois Chicago

Post-operative pain remains a frequent complication after root canal treatments. This clinical trial evaluates the post-operative outcome following endodontic treatments using four irrigation approaches: conventional needle irrigation, GentleWave®, EdgePRO™, and Fotona LightWalker®. The study will assess patients' post-operative pain and other symptoms following treatment, as well as healing of the tissues around the treated tooth over time.

Study Overview

Detailed Description

Conventional needle irrigation is the traditional method that uses a syringe and needle to deliver irrigation solutions into the root canal system to flush out tissue and debris in endodontic therapy. GentleWave®, EdgePRO™, and Fotona LightWalker® are advanced endodontic irrigation systems approved by the Federal Drug Administration as medical devices to prepare, clean, and irrigate root canal anatomy during endodontic therapy. The study compares the post-operative outcome between 4 groups: conventional needle irrigation, irrigation with GentleWave®, irrigation with EdgePRO™, and irrigation with Fotona LightWalker® in root canal treatments. Participants will be asked to report the level of post-operative pain by telephone at approximately 6, 24, 48, and 72 hours after treatment. Each pain assessment will take less than one minute. Participants will also be asked to return to the clinic for follow-up examinations at approximately 6 and 12 months after treatment. Each follow-up visit will take approximately 30 minutes.

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Anh M Bui, DMD
  • Phone Number: 847-749-6589
  • Email: abui20@uic.edu

Study Contact Backup

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60612
        • University of Illinois Chicago, College of Dentistry, Department of Endodontics
        • Contact:
        • Contact:
        • Principal Investigator:
          • Anh M Bui, DMD
        • Principal Investigator:
          • Qian Xie, BDS, MS, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adults older than 18 years of age who need root canal treatment.

Exclusion Criteria:

  • The intake of analgesics within the previous 8h, substance abuse, additional pulpal pathology on the same side, systemic conditions classified as ASA III or higher.
  • Adults unable to consent, minors less than 18 years of age, pregnant women, and prisoners

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Sham Comparator: Conventional needle irrigation

Conventional needle irrigation is the traditional method that uses a syringe and needle to deliver irrigation solutions into the root canal system to flush out tissue and debris in endodontic therapy.

Conventional needle irrigation is the traditional method that uses a syringe and needle to deliver irrigation solutions into the root canal system to flush out tissue and debris in endodontic therapy.

Post-operative pain information will be collected via phone interview.

Complications and adverse effects are the same as with other systems of similar design and traditional root canal therapy, and may include sensitivity, inflammation, and pain.

Active Comparator: Irrigation with GentleWave®

An advanced endodontic irrigation system that utilizes a vortex of fluids and acoustic energy that cleans the deepest, most complex portions of the root canal system.

An advanced endodontic irrigation system that utilizes a vortex of fluids and acoustic energy that cleans the deepest, most complex portions of the root canal system.

Regulatory approval status: FDA cleared

Post-operative pain information will be collected via phone interview.

Complications and adverse effects are the same as with other systems of similar design and traditional root canal therapy, and may include sensitivity, inflammation, and pain.

Active Comparator: Irrigation with EdgePRO™

An advanced endodontic irrigation system that delivers Laser Light Sound Energy at a specific wavelength and frequency to the irrigants in the canal to form Cavitation Waves throughout the root canal system. This allows optimal cleaning, debridement, and disinfection of the root canal system.

An advanced endodontic irrigation system that delivers Laser Light Sound Energy at a specific wavelength and frequency to the irrigants in the canal to form Cavitation Waves throughout the root canal system. This allows optimal cleaning, debridement, and disinfection of the root canal system.

Regulatory approval status: FDA cleared

Post-operative pain information will be collected via phone interview.

Complications and adverse effects are the same as with other systems of similar design and traditional root canal therapy, and may include sensitivity, inflammation, and pain.

Active Comparator: Irrigation with Fotona LightWalker®

An advanced endodontic irrigation system that combines Er:YAG and Nd:YAG wavelengths to optimize pulse control, intuitive interface, and minimally invasive approach to enhance patient outcomes, improve efficiency, and expand clinical capabilities.

An advanced endodontic irrigation system that combines Er:YAG and Nd:YAG wavelengths to optimize pulse control, intuitive interface, and minimally invasive approach to enhance patient outcomes, improve efficiency, and expand clinical capabilities.

Regulatory approval status: FDA cleared

Post-operative pain information will be collected via phone interview.

Complications and adverse effects are the same as with other systems of similar design and traditional root canal therapy, and may include sensitivity, inflammation, and pain.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post-operative pain intensity as assessed by the Numeric Rating Scale (NRS, 0-10)
Time Frame: 6, 24, 48, and 72 hours post-treatment

Pain intensity self-reported on an 11-point Numeric Rating Scale where 0 = no pain and 10 = worst possible pain. The metric is the mean NRS score per group, reported separately at each time point. Higher scores indicate worse pain.

6, 24, 48, and 72 hours post-treatment
Number of teeth with radiographic periapical healing as assessed by the Periapical Index (PAI)
Time Frame: 6- and 12-months post-treatment

Periapical status scored on the 5-point PAI (1 = normal periapical structures; 2 = small bone-structure changes; 3 = bone-structure changes with mineral loss; 4 = well-defined apical radiolucency; 5 = severe periodontitis with exacerbating features) on periapical radiographs by two calibrated, blinded, independent assessors, with a third assessor arbitrating disagreements. For multirooted teeth the highest root score is recorded. Based on the change in PAI between baseline and follow-up, each tooth is classified into one of three categories:

  1. Healing (complete healing): final PAI ≤ 2 with no clinical signs or symptoms (complete radiographic resolution).
  2. Incomplete healing: final PAI reduced compared with baseline but still > 2, with no clinical signs or symptoms (lesion reduced in size but not fully resolved).
  3. Unhealed: PAI unchanged or increased, and/or presence of clinical signs/symptoms (pain, swelling, sinus tract).

Reported as the proportion (number/total) of teeth.

6- and 12-months post-treatment
Number of teeth meeting clinical success criteria (absence of pain, swelling, sinus tract, and normal function)
Time Frame: 6 month and 12 month

Clinical success defined as a tooth with no spontaneous or provoked pain, no tenderness to percussion/palpation, no swelling, no sinus tract, and normal function. Reported as the proportion (number/total) of teeth meeting all criteria per group.

6 month and 12 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Analgesic consumption
Time Frame: At 6, 24, 48, and 72 hours post-treatment

Binary: present/absent

At 6, 24, 48, and 72 hours post-treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Qian Xie, BDS, MS, PhD, University of Illinois Chicago

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

October 1, 2028

Study Completion (Estimated)

October 1, 2028

Study Registration Dates

First Submitted

September 10, 2026

First Submitted That Met QC Criteria

September 25, 2026

First Posted (Actual)

October 1, 2026

Study Record Updates

Last Update Posted (Actual)

October 1, 2026

Last Update Submitted That Met QC Criteria

September 25, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2026-0972

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Information will be kept confidential at all times. No identifiable data will be collected.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe